Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study.
Saved in:
| Title: | Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study. |
|---|---|
| Authors: | Kian W; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Zemel M; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Kestenbaum EH; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Rouvinov K; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Alguayn W; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Levitas D; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Ievko A; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Michlin R; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Abod MA; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Massalha I; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Chernomordikov E; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Sharb AA; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Shalata W; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Levison E; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Roisman LC; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Lavrenkov K; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel., Peled N; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., Nesher L; Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beersheba, Israel., Yakobson A; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel. |
| Source: | Medicine [Medicine (Baltimore)] 2022 Jan 14; Vol. 101 (2), pp. e28561. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35029223 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kian+W%22">Kian W</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Zemel+M%22">Zemel M</searchLink>; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Kestenbaum+EH%22">Kestenbaum EH</searchLink>; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Rouvinov+K%22">Rouvinov K</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Alguayn+W%22">Alguayn W</searchLink>; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Levitas+D%22">Levitas D</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Ievko+A%22">Ievko A</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Michlin+R%22">Michlin R</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Abod+MA%22">Abod MA</searchLink>; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Massalha+I%22">Massalha I</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Chernomordikov+E%22">Chernomordikov E</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Sharb+AA%22">Sharb AA</searchLink>; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Shalata+W%22">Shalata W</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Levison+E%22">Levison E</searchLink>; Medical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Roisman+LC%22">Roisman LC</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Lavrenkov+K%22">Lavrenkov K</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Peled+N%22">Peled N</searchLink>; The Institute of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Nesher+L%22">Nesher L</searchLink>; Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beersheba, Israel.<br /><searchLink fieldCode="AU" term="%22Yakobson+A%22">Yakobson A</searchLink>; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center & Ben-Gurion University, Beer-Sheva, Israel. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985248R%22">Medicine</searchLink> [Medicine (Baltimore)] 2022 Jan 14; Vol. 101 (2), pp. e28561. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2985248R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1536-5964 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200257974%22">00257974 </searchLink><i>NLM ISO Abbreviation: </i>Medicine (Baltimore) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35029223 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/MD.0000000000028561 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e28561 Titles: – TitleFull: Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kian W – PersonEntity: Name: NameFull: Zemel M – PersonEntity: Name: NameFull: Kestenbaum EH – PersonEntity: Name: NameFull: Rouvinov K – PersonEntity: Name: NameFull: Alguayn W – PersonEntity: Name: NameFull: Levitas D – PersonEntity: Name: NameFull: Ievko A – PersonEntity: Name: NameFull: Michlin R – PersonEntity: Name: NameFull: Abod MA – PersonEntity: Name: NameFull: Massalha I – PersonEntity: Name: NameFull: Chernomordikov E – PersonEntity: Name: NameFull: Sharb AA – PersonEntity: Name: NameFull: Shalata W – PersonEntity: Name: NameFull: Levison E – PersonEntity: Name: NameFull: Roisman LC – PersonEntity: Name: NameFull: Lavrenkov K – PersonEntity: Name: NameFull: Peled N – PersonEntity: Name: NameFull: Nesher L – PersonEntity: Name: NameFull: Yakobson A IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 01 Text: 2022 Jan 14 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1536-5964 Numbering: – Type: volume Value: 101 – Type: issue Value: 2 Titles: – TitleFull: Medicine Type: main |
| ResultId | 1 |